Highlander Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.29M | Sell |
9,782
-1,200
| -11% | -$148K | 0.44% | 50 |
|
|
2023
Q4 | $1.2M | Buy |
10,982
+750
| +7% | +$77.9K | 0.43% | 53 |
|
|
2023
Q3 | $1.05M | Buy |
10,232
+7,400
| +261% | +$798K | 0.41% | 57 |
|
|
2023
Q2 | $327K | Hold |
2,832
| – | – | 0.15% | 120 |
|
|
2023
Q1 | $301K | Sell |
2,832
-1,000
| -26% | -$108K | 0.15% | 125 |
|
|
2022
Q4 | $425K | Hold |
3,832
| – | – | 0.22% | 93 |
|
|
2022
Q3 | $330K | Hold |
3,832
| – | – | 0.19% | 101 |
|
|
2022
Q2 | $349K | Hold |
3,832
| – | – | 0.19% | 100 |
|
|
2022
Q1 | $314K | Hold |
3,832
| – | – | 0.15% | 115 |
|
|
2021
Q4 | $294K | Hold |
3,832
| – | – | 0.14% | 120 |
|
|
2021
Q3 | $288K | Hold |
3,832
| – | – | 0.15% | 116 |
|
|
2021
Q2 | $298K | Sell |
3,832
-184
| -5% | -$13.7K | 0.15% | 116 |
|
|
2021
Q1 | $295K | Hold |
4,016
| – | – | 0.15% | 110 |
|
|
2020
Q4 | $313K | Hold |
4,016
| – | – | 0.17% | 106 |
|
|
2020
Q3 | $318K | Hold |
4,016
| – | – | 0.19% | 109 |
|
|
2020
Q2 | $296K | Hold |
4,016
| – | – | 0.19% | 112 |
|
|
2020
Q1 | $295K | Hold |
4,016
| – | – | 0.21% | 106 |
|
|
2019
Q4 | $349K | Hold |
4,016
| – | – | 0.2% | 109 |
|
|
2019
Q3 | $323K | Sell |
4,016
-524
| -12% | -$42K | 0.2% | 114 |
|
|
2019
Q2 | $363K | Sell |
4,540
-210
| -4% | -$16.1K | 0.22% | 109 |
|
|
2019
Q1 | $377K | Hold |
4,750
| – | – | 0.23% | 106 |
|
|
2018
Q4 | $345K | Sell |
4,750
-157
| -3% | -$11.1K | 0.23% | 104 |
|
|
2018
Q3 | $332K | Sell |
4,907
-3,511
| -42% | -$224K | 0.18% | 124 |
|
|
2018
Q2 | $488K | Sell |
8,418
-157
| -2% | -$8.86K | 0.28% | 93 |
|
|
2018
Q1 | $436K | Buy |
8,575
+5,240
| +157% | +$283K | 0.26% | 100 |
|
|
2017
Q4 | $179K | Hold |
3,335
| – | – | 0.13% | 176 |
|
|
2017
Q3 | $204K | Buy |
3,335
+524
| +19% | +$31.8K | 0.16% | 157 |
|
|
2017
Q2 | $172K | Hold |
2,811
| – | – | 0.14% | 175 |
|
|
2017
Q1 | $170K | Hold |
2,811
| – | – | 0.14% | 173 |
|
|
2016
Q4 | $158K | Hold |
2,811
| – | – | 0.14% | 181 |
|
|
2016
Q3 | $167K | Hold |
2,811
| – | – | 0.15% | 172 |
|
|
2016
Q2 | $155K | Hold |
2,811
| – | – | 0.14% | 180 |
|
|
2016
Q1 | $142K | Hold |
2,811
| – | – | 0.13% | 188 |
|
|
2015
Q4 | $142K | Buy |
2,811
+53
| +2% | +$2.67K | 0.13% | 186 |
|
|
2015
Q3 | $130K | Hold |
2,758
| – | – | 0.12% | 198 |
|
|
2015
Q2 | $150K | Sell |
2,758
-645
| -19% | -$36.2K | 0.13% | 181 |
|
|
2015
Q1 | $187K | Buy |
3,403
+53
| +2% | +$3K | 0.16% | 151 |
|
|
2014
Q4 | $182K | Buy |
3,350
+120
| +4% | +$6.69K | 0.16% | 163 |
|
|
2014
Q3 | $183K | Hold |
3,230
| – | – | 0.17% | 143 |
|
|
2014
Q2 | $178K | Sell |
3,230
-183
| -5% | -$9.98K | 0.16% | 150 |
|
|
2014
Q1 | $185K | Hold |
3,413
| – | – | 0.17% | 147 |
|
|
2013
Q4 | $163K | Hold |
3,413
| – | – | 0.15% | 165 |
|
|
2013
Q3 | $155K | Hold |
3,413
| – | – | 0.16% | 161 |
|
|
2013
Q2 | $151K | Buy |
+3,413
| New | +$152K | 0.16% | 165 |
|
Other funds holding MRK
Highlander Capital Management's MRK Position: Q1 2024 in Review
Highlander Capital Management reduced its Merck (MRK) stake by 11% in Q1 2024, selling an estimated $148K and leaving 9,782 shares worth $1.29M. The position accounts for 0.44% of the portfolio, ranked #50.
Highlander Capital Management first reported a position in MRK in Q2 2013 and has held it in 44 quarters since. 3,536 funds tracked by Wall St. Rank hold MRK as of Q1 2024.
- Highlander Capital Management held 9,782 shares of Merck worth $1.29M as of Q1 2024.
- Highlander Capital Management sold 1,200 Merck shares in Q1 2024, an estimated $148K.
- Merck made up 0.44% of Highlander Capital Management's portfolio in Q1 2024, its #50 holding.
- Highlander Capital Management first reported a position in Merck in Q2 2013 and has held it in 44 quarters since.
- 3,536 funds tracked by Wall St. Rank held Merck as of Q1 2024.
Based on Highlander Capital Management's 13F filing for Q1 2024, filed 20 May 2024.